David Gilot

3.6k total citations
54 papers, 2.2k citations indexed

About

David Gilot is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, David Gilot has authored 54 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Hepatology. Recurrent topics in David Gilot's work include Liver physiology and pathology (8 papers), Toxic Organic Pollutants Impact (8 papers) and RNA Interference and Gene Delivery (5 papers). David Gilot is often cited by papers focused on Liver physiology and pathology (8 papers), Toxic Organic Pollutants Impact (8 papers) and RNA Interference and Gene Delivery (5 papers). David Gilot collaborates with scholars based in France, Australia and United States. David Gilot's co-authors include Olivier Fardel, Christiane Guguen‐Guillouzo, Marie‐Dominique Galibert, Dominique Lagadic‐Gossmann, Pascal Loyer, Eric Le Ferrec, Valérie Lecureur, Laura Bachelot, Georges Baffet and Anaïs M. Quéméner and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

David Gilot

54 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gilot France 25 1.0k 347 307 303 303 54 2.2k
Lesley M. Forrester United Kingdom 36 2.7k 2.6× 383 1.1× 499 1.6× 74 0.2× 566 1.9× 86 4.5k
Richard R. Vaillancourt United States 24 1.6k 1.5× 225 0.6× 393 1.3× 108 0.4× 242 0.8× 37 2.3k
Lorenza Tacchini Italy 28 1.3k 1.2× 567 1.6× 186 0.6× 57 0.2× 210 0.7× 74 2.8k
Rong Cong China 21 1.3k 1.3× 726 2.1× 417 1.4× 46 0.2× 411 1.4× 92 2.4k
Aijuan Qu China 32 1.3k 1.3× 596 1.7× 252 0.8× 38 0.1× 270 0.9× 66 2.9k
Richard Edwards United Kingdom 24 580 0.6× 202 0.6× 253 0.8× 139 0.5× 156 0.5× 55 1.5k
Lei He China 25 985 1.0× 338 1.0× 584 1.9× 838 2.8× 137 0.5× 48 2.8k
Ying‐Hue Lee United States 16 1.3k 1.3× 287 0.8× 457 1.5× 62 0.2× 270 0.9× 24 2.6k
Almudena Porrás Spain 27 2.3k 2.2× 481 1.4× 694 2.3× 46 0.2× 392 1.3× 72 3.6k
Wei Yan China 30 1.4k 1.3× 471 1.4× 312 1.0× 156 0.5× 803 2.7× 91 2.8k

Countries citing papers authored by David Gilot

Since Specialization
Citations

This map shows the geographic impact of David Gilot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gilot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gilot more than expected).

Fields of papers citing papers by David Gilot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gilot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gilot. The network helps show where David Gilot may publish in the future.

Co-authorship network of co-authors of David Gilot

This figure shows the co-authorship network connecting the top 25 collaborators of David Gilot. A scholar is included among the top collaborators of David Gilot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gilot. David Gilot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menchon, Grégory, et al.. (2025). A genome-wide CRISPR screen unveils the endosomal maturation protein WDR91 as a promoter of productive ASO activity in melanoma. Molecular Therapy — Nucleic Acids. 36(3). 102577–102577. 1 indexed citations
2.
Leclerc, Delphine, Sylvie Jaillard, Léna Damaj, et al.. (2023). Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient. The CRISPR Journal. 6(1). 17–31. 2 indexed citations
3.
Leclerc, Delphine, Audrey Labalme, Pascale Bellaud, et al.. (2023). Functional Assessment of a New PBX1 Variant in a 46,XY Fetus with Severe Syndromic Difference of Sexual Development through CRISPR-Cas9 Gene Editing. Genes. 14(2). 273–273. 1 indexed citations
4.
Quéméner, Anaïs M., Laura Bachelot, Marc Aubry, et al.. (2022). Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16. Life Science Alliance. 5(12). e202201643–e202201643. 4 indexed citations
5.
Mottier, Stéphanie, Aline Primot, Édouard Cadieu, et al.. (2022). Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets. Cancers. 14(2). 276–276. 13 indexed citations
6.
Leclerc, Delphine, et al.. (2022). The TALE never ends: A comprehensive overview of the role of PBX1, a TALE transcription factor, in human developmental defects. Human Mutation. 43(9). 1125–1148. 8 indexed citations
7.
Bachelot, Laura, Marc Aubry, Delphine Leclerc, et al.. (2021). CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance. EMBO Molecular Medicine. 13(5). e13466–e13466. 21 indexed citations
8.
Angenard, Gaëlle, Raphaël Pineau, Stefano Caruso, et al.. (2021). TGFβ‐induced FOXS1 controls epithelial–mesenchymal transition and predicts a poor prognosis in liver cancer. Hepatology Communications. 6(5). 1157–1171. 13 indexed citations
9.
Gilot, David, Seong Beom Ahn, Vincent K. Lam, et al.. (2021). Involvement of Kynurenine Pathway in Hepatocellular Carcinoma. Cancers. 13(20). 5180–5180. 17 indexed citations
10.
Leclerc, Delphine, Ananda Staats Pires, Gilles J. Guillemin, & David Gilot. (2021). Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies. Current Opinion in Immunology. 70. 15–26. 59 indexed citations
11.
Quéméner, Anaïs M., et al.. (2020). The powerful world of antisense oligonucleotides: From bench to bedside. Wiley Interdisciplinary Reviews - RNA. 11(5). e1594–e1594. 200 indexed citations
12.
Deplanche, Martine, Aurélie Nicolas, Minh‐Thu Nguyen, et al.. (2020). Involvement of caspase‐1 in inflammasomes activation and bacterial clearance in S. aureus ‐infected osteoblast‐like MG ‐63 cells. Cellular Microbiology. 22(8). e13204–e13204. 12 indexed citations
13.
Bachelot, Laura, et al.. (2020). Human TYRP1: Two functions for a single gene?. Pigment Cell & Melanoma Research. 34(5). 836–852. 18 indexed citations
14.
Felden, Brice & David Gilot. (2018). Modulation of Bacterial sRNAs Activity by Epigenetic Modifications: Inputs from the Eukaryotic miRNAs. Genes. 10(1). 22–22. 11 indexed citations
15.
Corre, Sébastien, Nicolas Mouchet, Héloïse M. Leclair, et al.. (2018). Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma. Nature Communications. 9(1). 4775–4775. 81 indexed citations
16.
Gilot, David & Marie‐Dominique Galibert. (2017). miRNA displacement as a promising approach for cancer therapy. Molecular & Cellular Oncology. 5(1). e1406432–e1406432. 3 indexed citations
17.
Gilot, David, et al.. (2010). Akti-1/2, an allosteric inhibitor of Akt 1 and 2, efficiently inhibits CaMKIα activity and aryl hydrocarbon receptor pathway. Chemico-Biological Interactions. 188(3). 546–552. 20 indexed citations
18.
Podechard, Normand, Valérie Lecureur, Eric Le Ferrec, et al.. (2008). Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation. Toxicology Letters. 177(2). 130–137. 120 indexed citations
19.
Monteiro, Patricia, David Gilot, Eric Le Ferrec, et al.. (2007). AhR- and c-maf-dependent induction of β7-integrin expression in human macrophages in response to environmental polycyclic aromatic hydrocarbons. Biochemical and Biophysical Research Communications. 358(2). 442–448. 28 indexed citations
20.
Gilot, David, Anne‐Laure Sérandour, Dominique Lagadic‐Gossmann, et al.. (2005). A role for caspase-8 and c-FLIP L in proliferation and cell-cycle progression of primary hepatocytes. Carcinogenesis. 26(12). 2086–2094. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lesley M. Forrester Breakdown of academic impact, for papers by Richard R. Vaillancourt Breakdown of academic impact, for papers by Lorenza Tacchini Breakdown of academic impact, for papers by Rong Cong Breakdown of academic impact, for papers by Aijuan Qu Breakdown of academic impact, for papers by Richard Edwards Breakdown of academic impact, for papers by Lei He Breakdown of academic impact, for papers by Ying‐Hue Lee Breakdown of academic impact, for papers by Almudena Porrás Breakdown of academic impact, for papers by Wei Yan
Rankless by CCL
2026